CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes EVP, Human Resources gave up 223 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 1,470 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 4 Grant or award Director acquired 890 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 2,434 shares at an average $295.22 ($718,574)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,150 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Research & Development gave up 538 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 130 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Off & Corp Sec gave up 689 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 46 shares (to pay taxes)
Page 16 of 86 · 1,714 filings